Sitaglit Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Side Effects Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Sitagliptin

Indications/Uses

Adjunct to diet & exercise to improve glycemic control in adults w/ type 2 DM as monotherapy, or in combination w/ metformin, sulfonylurea or thiazolidinediones when diet & exercise plus a single agent does not result in adequate glycemic control.

Click to view Sitaglit detailed prescribing information

Dosage/Direction for Use

100 mg once daily. Moderate renal insufficiency (CrCl >30 to <50 mL/min, women) 50 mg once daily. Severe renal insufficiency (CrCl <30 mL/min) or w/ end-stage renal disease (ESRD) 25 mg once daily.

Click to view Sitaglit detailed prescribing information

Overdosage

View Sitaglit overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food.

Contraindications

Hypersensitivity reactions eg, anaphylaxis, angioedema & exfoliative skin conditions including Stevens-Johnson syndrome.

Click to view Sitaglit detailed prescribing information

Special Precautions

Moderate or severe renal insufficiency & in patients w/ ESRD. Pregnancy & lactation. Elderly & childn.

Click to view Sitaglit detailed prescribing information

Use In Pregnancy & Lactation

Click to view Sitaglit detailed prescribing information

Adverse Reactions

Upper resp tract infection, nasopharyngitis & headache; hypoglycemia.

Drug Interactions

Increased AUC & C_maxof digoxin.

Click to view Sitaglit detailed prescribing information

Storage

View Sitaglit storage conditions for details to ensure optimal shelf-life.

Description

View Sitaglit description for details of the chemical structure and excipients (inactive components).

Action

View Sitaglit mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Antidiabetic Agents

ATC Classification

A10BH01 - sitagliptin ; Belongs to the class of dipeptidyl peptidase 4 (DPP-4) inhibitors. Used in the treatment of diabetes.

Regulatory Classification

POM

Presentation/Packing

Form

Sitaglit FC tab 100 mg

Packing/Price

1 × 10's

Form

Sitaglit FC tab 50 mg

Packing/Price

1 × 10's

Sitaglit

sitagliptin

Manufacturer:

Healthcare Pharma

Distributor:

San Lwin Trading

Marketer:

San Lwin Trading